MGI PHARMA, INC.
(Company has closed.)
<b>Press releases archived for reference only.</b>
Bloomington
Minnesota
United States
46 articles about MGI PHARMA, INC.
-
Japan's Eisai Company, Ltd. to Buy U.S. MGI PHARMA, INC. (Jobs) for $3.9 Billion
12/10/2007
-
MGI PHARMA, INC. Issues Statement
11/29/2007
-
MGI PHARMA, INC. To Present at the Lazard Capital Markets 4th Annual Healthcare Conference
11/20/2007
-
MGI PHARMA, INC. Reports Third Quarter 2007 Financial Results
10/18/2007
-
MGI PHARMA, INC.'s Aloxi(R) Phase 3 Data for Post Operative Nausea and Vomiting (PONV) Presented at the Annual Meeting of the American Society of Anesthesiologists (ASA)
10/15/2007
-
AkaRx, Inc. and MGI PHARMA, INC. Announce Closing of Development and License Agreement
10/11/2007
-
MGI PHARMA, INC. Announces Change to Presentation Time at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Devices Conference
9/19/2007
-
MGI PHARMA, INC. Third Quarter 2006 Financial Results Conference Call to Be Webcast On October 18, 2006
10/11/2006
-
The Week In Review: A Late Summer Bounce For Biotech
9/5/2006
-
MGI PHARMA, INC. To Present At The Bear Stearns 19th Annual Healthcare Conference
9/5/2006
-
Company Profile For MGI PHARMA, INC.
9/1/2006
-
MGI PHARMA, INC. Dacogen(TM) (Decitabine) For Injection Receives U.S. Orphan Drug Designation For Patients With AML
8/10/2006
-
The Day In Review: Nuvelo, Inc. Expands Archemix Corporation Deal
8/1/2006
-
MGI PHARMA, INC.'s Dacogen(TM) (Decitabine) For Injection Receives European Orphan Drug Designation For Patients With AML
8/1/2006
-
SuperGen, Inc. Announces Attainment Of Milestone From The MGI PHARMA, INC. / Cilag GmbH, A Johnson & Johnson, Licensing For Dacogen(TM) (Decitabine) For Injection
7/6/2006
-
U.S. FDA Approves MGI PHARMA, INC.'s Dacogen(TM) (Decitabine) For Injection
5/3/2006
-
The Day In Review: Biogen Idec, Inc. (Massachusetts) Buys Cancer Company Conforma Therapeutics Corporation
5/3/2006
-
MGI PHARMA, INC. Appoints William F. Spengler As CFO
4/24/2006
-
MGI PHARMA, INC. Reports First Quarter 2006 Financial Results
4/20/2006
-
The Day In Review: Amgen Pretty Much Hits Its Numbers
4/18/2006